Tower Research Capital LLC (Trc) Sab Biotherapeutics, Inc. Transaction History

Tower Research Capital LLC (Trc)

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 13, 2024	BUY	$0.62 - $1.0 $182 - $295	295 Added 1.97%	15,235 $10,000
Q3 2023 Nov 14, 2023	BUY	$0.47 - $0.9 $185 - $355	395 Added 2.72%	14,940 $9,000
Q2 2023 Aug 14, 2023	SELL	$0.38 - $1.09 $576 - $1,653	-1,517 Reduced 9.44%	14,545 $12,000
Q1 2023 May 09, 2023	BUY	$0.42 - $0.75 $1,953 - $3,488	4,651 Added 40.76%	16,062 $7,000
Q4 2022 Feb 10, 2023	SELL	$0.54 - $9.8 $1,204 - $21,863	-2,231 Reduced 16.35%	11,411 $7,000
Q3 2022 Nov 10, 2022	BUY	$0.13 - $12.4 $710 - $67,778	5,466 Added 66.85%	13,642 $10,000
Q2 2022 Aug 15, 2022	BUY	$1.11 - $3.46 $7,153 - $22,299	6,445 Added 372.33%	8,176 $12,000
Q1 2022 May 12, 2022	BUY	$1.78 - $8.5 $295 - $1,411	166 Added 10.61%	1,731 $7,000
Q4 2021 Feb 14, 2022	BUY	$7.3 - $11.24 $11,424 - $17,590	1,565 New	1,565 $12,000

529K

Ticker SABS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 43,030,900
Market Cap $111M
Description
SAB Biotherapeutics, Inc., a clinical-stage biopharmaceutical company, engages in the development of immunotherapies based on human antibodies. It has applied advanced genetic engineering and antibody science to develop transchromosomic bovine herds that produce fully human antibodies targeted at specific diseases, including infectious diseases ...

Get notified when there are updates to the investment portfolio of Tower Research Capital LLC (Trc), based on Form 13F filings with the SEC.

Stay updated on Tower Research Capital LLC (Trc) with notifications on news.